Clinical Trial Update: Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing a Phase 1/2 study of sequential infusion of CD146-targeted and HER2-targeted CAR T cells in patients with advanced sarcomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Ewing Sarcoma
• Germinoblastic Sarcoma
• Kaposi Sarcoma
• Sarcoma
• Soft Tissue Sarcoma
• Synovial Sarcoma

Drugs mentioned

• CD146-targeted CAR T cells (CD146-targeted CAR T cells)
• HER2-targeted CAR T cells (HER2-targeted CAR T cells)

Snippet

Sponsor: Essen Biotech | Conditions: Sarcoma, Sarcoma, Kaposi | Phase 1, Phase 2 | Status: RECRUITING